Journal: Molecular cell
Article Title: Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.
doi: 10.1016/j.molcel.2019.06.030
Figure Lengend Snippet: Figure 5. Sensing of De Novo Synthesized Nascent Chains by NAC Ribosome binding of NAC is mediated by a ribosome-binding regulatory arm (N-aNAC) and a translation sensor domain (N-bNAC). N-aNAC directly contacts the ribosome close to the tunnel exit but also possesses a ribosome binding inhibitory element that interacts with eL19. The empty tunnel of idle and early-stage translating ribosomes is sensed by N-bNAC, which inserts deeply into the ribosomal tunnel up to the constriction formed by uL22. In the tunnel-inserted conformation, NAC blocks the premature, unproductive ribosome association of Sec61 and likely of other cotranslational protein biogenesis factors, including RAC and SRP (left, early state). During polypeptide elongation, N-bNAC senses short nascent chains and is partially pushed out of the ribosomal tunnel, which likely repositions the NAC domain outside the tunnel (dotted arrows) to facilitate the early recruitment of other protein biogenesis factors, like SRP (middle, intermediate state). Once the N-bNAC tail is completely pushed out of the tunnel, it can relocate to an alternate binding site on the ribosome surface involving eL22 and eL31 (right, late stage). At this stage, NAC may orchestrate cotranslational protein folding and targeting processes by regulating the specific binding of other chaperones and targeting factors. MTS, mitochondrial targeting sequence; SS, endoplasmic reticulum signal sequence; TMD, transmembrane domain.
Article Snippet: Antibodies used throughout this study were FLAG (F7425, Sigma), uL16 (AP17603a, Abgent), eL19 (sc-100830, Santa Cruz), uL22 (14121-1-AP, Proteintech), eL22 (25002-1-AP, Proteintech), eL39 (14990-1-AP, Proteintech), uL4 (sc-100838, Santa Cruz), Gapdh (sc-137179, Santa Cruz), Actin (sc-47778, Santa Cruz), human aNAC (40-1000, Invitrogen), human bNAC (ab66940, Abcam), Puromycin (MABE343, Merck), HSP4/GRP78 (PA5-22967, Thermo Scientific), Sec61a (sc-393182, Santa Cruz), and PDI3 (kind gift of Antony Page, University of Glasgow, Scotland (Eschenlauer and Page, 2003)).
Techniques: Synthesized, Binding Assay, Sequencing